Valentin Voillet

14PUBLICATIONS
116CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical mycologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 09, 2026
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.

|Jan 03, 2026
A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands.

Shihong Zhang, Tzu-Hao Tang, Sinéad Kinsella

|Sep 22, 2025
Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer.

Gabriel F Alencar, Asmaa O Mohamed, Madison G Burnett

|Jun 05, 2025
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.

Francesco Mazziotta, Lauren E Martin, Daniel N Egan

|Sep 16, 2024
Probing Dermal Immunity to Mycobacteria through a Controlled Human Infection Model.

E Chandler Church, Emma Bishop, Andrew Fiore-Gartland

|Jun 18, 2024
Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis.

One B Dintwe, Lamar Ballweber Fleming, Valentin Voillet

Pageof 3

Frequent Collaborators

6 joint publications

Raphaël Gottardo

5 joint publications

Cecilia Yeung

4 joint publications

Aude G Chapuis

3 joint publications

Anthony Rongvaux